Figure 3.
(A) Positron emission tomography (PET)-CT imaging with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) revealing an undetermined nodular lesion in the posterior gastric body wall, suggestive of a neoplastic process (black arrow). (B) CT scan revealed a lesion in the gastric body, measuring 1.9 cm (white arrow). (C) Genetic investigation revealed a germline SDHC exon 3 deletion detected using multiplex ligation-dependent probe amplification (MLPA). CT, computed tomography; GIST, gastrointestinal stromal tumor.

(A) Positron emission tomography (PET)-CT imaging with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) revealing an undetermined nodular lesion in the posterior gastric body wall, suggestive of a neoplastic process (black arrow). (B) CT scan revealed a lesion in the gastric body, measuring 1.9 cm (white arrow). (C) Genetic investigation revealed a germline SDHC exon 3 deletion detected using multiplex ligation-dependent probe amplification (MLPA). CT, computed tomography; GIST, gastrointestinal stromal tumor.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close